These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 934562)
21. Fondaparinux as anticoagulant in a pregnant woman with heparin allergy. Wijesiriwardana A; Lees DA; Lush C Blood Coagul Fibrinolysis; 2006 Mar; 17(2):147-9. PubMed ID: 16479197 [TBL] [Abstract][Full Text] [Related]
22. Anticoagulant therapy: through a glass darkly. Hampton JW Am Fam Physician; 1974 Feb; 9(2):100-4. PubMed ID: 4810867 [No Abstract] [Full Text] [Related]
23. Fixed mini-dose warfarin for prophylaxis of thromboembolic disease in pregnancy: a safe alternative for the fetus? Porreco RP; McDuffie RS; Peck SD Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):806-7. PubMed ID: 8469479 [TBL] [Abstract][Full Text] [Related]
24. Intensive initial oral anticoagulation and shorter heparin treatment in deep vein thrombosis. Schulman S; Lockner D; Bergström K; Blombäck M Thromb Haemost; 1984 Dec; 52(3):276-80. PubMed ID: 6397871 [TBL] [Abstract][Full Text] [Related]
27. Sublingual administration of warfarin: a novel form of delivery. Batke-Hastings S; Carman TL Vasc Med; 2008; 13(2):123-6. PubMed ID: 18593801 [TBL] [Abstract][Full Text] [Related]
28. Problems of deep venous thrombosis during pregnancy. Pfeifer GW; von Nathusius U Acta Univ Carol Med Monogr; 1972; 52():193-4. PubMed ID: 4669822 [No Abstract] [Full Text] [Related]
29. Anticoagulation. Current approach to heparin and warfarin therapy. Painter TD Postgrad Med; 1983 Sep; 74(3):341-5, 348, 350. PubMed ID: 6889207 [TBL] [Abstract][Full Text] [Related]
33. Cerebral venous thrombosis due to protein S deficiency in pregnancy. Burneo JG; Elias SB; Barkley GL Lancet; 2002 Mar; 359(9309):892. PubMed ID: 11897316 [No Abstract] [Full Text] [Related]
34. Pharmacokinetic optimisation of the treatment of deep vein thrombosis. Iorio A; Agnelli G Clin Pharmacokinet; 1997 Feb; 32(2):145-72. PubMed ID: 9068929 [TBL] [Abstract][Full Text] [Related]
35. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Levine MN; Hirsh J; Gent M; Turpie AG; Weitz J; Ginsberg J; Geerts W; LeClerc J; Neemeh J; Powers P Thromb Haemost; 1995 Aug; 74(2):606-11. PubMed ID: 8584992 [TBL] [Abstract][Full Text] [Related]
36. Peri-operative anticoagulant therapy--the case for an uninterrupted dose-adjusted warfarin regimen in the high-risk patient. Franz RC S Afr J Surg; 2006 Aug; 44(3):84, 86. PubMed ID: 16958233 [No Abstract] [Full Text] [Related]
37. Anticoagulation in pregnant patients with mechanical heart valves: clinical considerations. Stout MJ; Odibo AO Clin Lab Med; 2013 Jun; 33(2):357-65. PubMed ID: 23702123 [TBL] [Abstract][Full Text] [Related]
38. [Intravenous heparin therapy of deep venous thrombosis during pregnancy]. Dahle MG Tidsskr Nor Laegeforen; 1988 Aug; 108(22):1661. PubMed ID: 3413758 [No Abstract] [Full Text] [Related]
39. Chronically anticoagulated patients who need surgery: can low-molecular-weight heparins really be used to "bridge" patients instead of intravenous unfractionated heparin? Jaff MR Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S17-21. PubMed ID: 19213061 [TBL] [Abstract][Full Text] [Related]
40. [Low-molecular weight heparin in the treatment of pregnant women with high thrombotic risk]. Todorova K; Mazneĭkova V; Ivanov S Akush Ginekol (Sofiia); 2004; 43(4):46-52. PubMed ID: 15318544 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]